Chemistry and biology of protein histidine phosphorylation

蛋白质组氨酸磷酸化的化学和生物学

基本信息

  • 批准号:
    8024090
  • 负责人:
  • 金额:
    $ 9.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-12-15 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A research program will be undertaken to study the role of histidine phosphorylation in eukaryotic cells. While protein phosphorylation is known to occur on several amino acids, it is fair to say that phosphoserine, phosphothreonine and phosphotyrosine capture most of the attention in the literature, at least as it pertains to cellular signaling in higher eukaryotes. This proposal turns the spotlight away from this group towards phosphohistidine (pHis). Phosphorylation of histidine is well recognized as being critical to signaling processes in prokaryotes and lower eukaryotes. However, pHis is becoming widely reported in mammalian signaling pathways and implicated in certain human disease states such as cancer and inflammation. Nonetheless, much remains to be understood about the role and extent of the modification in mammalian cell biology. Indeed, studying the functional role of pHis in signaling, either in vitro or in vivo, has proven devilishly hard, largely due to the instability of the modification. As a consequence, we are currently handicapped by a chronic lack of chemical and biochemical tools with which to study histidine phosphorylation. It is this problem that we seek to address in this research program. We have recently synthesized novel stable mimetics of pHis and used these to successfully raise the first antibodies against this modification in proteins. This breakthrough serves as the starting point for the proposed research program in which we will investigate the functional role of histidine phosphorylation on histone H4. It has long been known that histone H4 is phosphorylated on histidines 18 and 75. The precise role of this post-translational modification (PTM) is unknown, nor is the kinase that installs the PTM. A correlation exists between histone H4 histidine kinase activity and cell proliferation and, indeed, this activity is dramatically upregulated in certain cancer cells, specifically, in human hepato-carcinoma cells. We will use protein engineering methods in conjunction with a series of biochemical and biophysical approaches to test the hypothesis that histidine phosphorylation of H4 alters the compaction state of chromatin in a cell cycle dependent manner. The specific aims of this proposal are: (i) To develop a suite of antibodies against pHis epitopes with uses in the area of chromatin biology and beyond; (ii) To characterize the H4 histidine kinase and to identify H4 pHis binding factors, and; (iii) To elucidate the functional and structural role of H4 histidine phosphorylation in chromatin. This research program is designed to provide much needed research tools for studying pHis in cellular signaling. With these in hand, we will take the first steps towards elucidating the role of this PTM in chromatin biology. We expect this work to lay the foundation for understanding the role of this generally overlooked PTM in epigenetic regulatory mechanisms, a long term goal of this program. PUBLIC HEALTH RELEVANCE: This research program focuses on one of the most poorly understood protein post-translational modifications in eukaryotic cells, namely histidine phosphorylation (pHis). pHis is well known to play a central role in prokaryotic cell signaling processes, however, the modification also occurs in mammalian cells where it has been implicated in certain human disease states such as cancer and inflammation. Studying pHis is devilishly hard due to its chemical instability; indeed, there is a paucity of research tools that allow the full biology of this modification to be uncovered. This research program will address this pressing problem by providing a biochemical toolbox for studying the function of pHis both generally and, of more immediate interest to us, as it pertains to the regulation of chromatin, the repository of DNA in the nucleus of mammalian cells.
描述(由申请人提供):将进行一项研究计划,以研究组氨酸磷酸化在真核细胞中的作用。虽然已知蛋白质磷酸化发生在几种氨基酸上,但可以说,磷酸磷酸,磷酸苏氨酸和磷酸酪氨酸在文献中捕获大多数注意力,至少与较高真核生物中的细胞信号有关。该提议使人们的聚光灯从该群体转向磷酸组织(PHIS)。组氨酸的磷酸化被广泛认为是原核生物和较低真核生物的信号传导过程至关重要。但是,PHI在哺乳动物信号通路中广泛报道,并与某些人类疾病状态(如癌症和炎症)有关。尽管如此,关于修饰在哺乳动物细胞生物学中的作用和程度仍然有待理解。实际上,研究PHI在体外或体内信号传导中的功能作用已被证明是艰难的,这主要是由于修饰的不稳定性。结果,我们目前受到慢性缺乏化学和生化工具来研究组氨酸磷酸化的方法。我们在此研究计划中寻求解决这个问题。我们最近合成了新型PHIS的新型稳定模拟物,并使用它们成功地提出了针对蛋白质修饰的首批抗体。这一突破是拟议研究计划的起点,在该计划中,我们将研究组氨酸磷酸化在组蛋白H4上的功能作用。早就知道,组蛋白H4在组氨酸18和75上磷酸化。这种翻译后修饰(PTM)的确切作用尚不清楚,安装PTM的激酶也不是。组蛋白H4组氨酸激酶活性与细胞增殖之间存在相关性,实际上,在某些癌细胞中,特别是在人肝癌细胞中,该活性显着​​上调。我们将使用蛋白质工程方法与一系列生化和生物物理方法结合使用,以测试H4的组氨酸磷酸化以细胞周期依赖性方式改变染色质的压实状态。该提案的具体目的是:(i)开发一套针对Phis表位的抗体,并在染色质生物学及其他地区使用; (ii)表征H4组氨酸激酶并鉴定H4 PHIS结合因子,并且; (iii)阐明H4组氨酸磷酸化在染色质中的功能和结构作用。该研究计划旨在提供急需的研究工具,用于研究细胞信号中的PHI。借助这些,我们将迈出第一步,以阐明该PTM在染色质生物学中的作用。我们希望这项工作为理解这种普遍忽视的PTM在表观遗传调节机制中的作用奠定了基础,这是该计划的长期目标。 公共卫生相关性:该研究计划侧重于真核细胞中最糟糕的蛋白质翻译后修饰之一,即组氨酸磷酸化(PHIS)。众所周知,PHI在原核细胞信号传导过程中起着核心作用,但是,这种修饰也发生在哺乳动物细胞中,在哺乳动物细胞中与某些人类疾病状态(例如癌症和炎症)有关。由于其化学不稳定性,研究PHI非常困难。确实,很少有研究工具可以发现这种修饰的全部生物学。该研究计划将通过提供一个生化工具箱来解决这个紧迫的问题,用于研究PHIS的功能,并且我们对我们更直接感兴趣的功能,因为它与染色质的调节有关,这是哺乳动物细胞核中DNA的储存库。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Tom Muir的其他基金

Project 3: Mechanisms of Methyltransferase Dysregulation by Oncohistones
项目 3:肿瘤组蛋白甲基转移酶失调的机制
  • 批准号:
    10024845
    10024845
  • 财政年份:
    2015
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Project 3: Mechanisms of Methyltransferase Dysregulation by Oncohistones
项目 3:肿瘤组蛋白甲基转移酶失调的机制
  • 批准号:
    10269906
    10269906
  • 财政年份:
    2015
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Development and Applications of 'Designer Chromatin'
“设计师染色质”的开发和应用
  • 批准号:
    9060364
    9060364
  • 财政年份:
    2013
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Development and Applications of 'Designer Chromatin'
“设计师染色质”的开发和应用
  • 批准号:
    8556589
    8556589
  • 财政年份:
    2013
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Development and Applications of 'Designer Chromatin'
“设计师染色质”的开发和应用
  • 批准号:
    8875016
    8875016
  • 财政年份:
    2013
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
TARGETS OF A MECHANISM-BASED PROBE AGAINST CYSTEINE PROTEASES
基于机制的半胱氨酸蛋白酶探针的靶标
  • 批准号:
    8361536
    8361536
  • 财政年份:
    2011
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
TARGETS OF A MECHANISM-BASED PROBE AGAINST CYSTEINE PROTEASES
基于机制的半胱氨酸蛋白酶探针的靶标
  • 批准号:
    8169165
    8169165
  • 财政年份:
    2010
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Chemistry and biology of protein histidine phosphorylation
蛋白质组氨酸磷酸化的化学和生物学
  • 批准号:
    8587489
    8587489
  • 财政年份:
    2010
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Chemistry and biology of protein histidine phosphorylation
蛋白质组氨酸磷酸化的化学和生物学
  • 批准号:
    8204490
    8204490
  • 财政年份:
    2010
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Chemistry and biology of protein histidine phosphorylation
蛋白质组氨酸磷酸化的化学和生物学
  • 批准号:
    8413055
    8413055
  • 财政年份:
    2010
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:

相似国自然基金

PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
  • 批准号:
    32202823
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
聚氨基酸用于蛋白质翻译后修饰泛抗体的诱导与制备
  • 批准号:
    22105008
  • 批准年份:
    2021
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
基于非天然氨基酸光交联的表位靶向抗体筛选及其应用研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
磷酸化组氨酸(pHis)的抗体富集、质谱鉴定及生物功能研究
  • 批准号:
    91953103
  • 批准年份:
    2019
  • 资助金额:
    60.0 万元
  • 项目类别:
    重大研究计划

相似海外基金

Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
  • 批准号:
    10589192
    10589192
  • 财政年份:
    2023
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
  • 批准号:
    10597840
    10597840
  • 财政年份:
    2023
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
  • 批准号:
    10658665
    10658665
  • 财政年份:
    2023
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
LINE1-ORF0 in SLE pathogenesis
SLE 发病机制中的 LINE1-ORF0
  • 批准号:
    10681876
    10681876
  • 财政年份:
    2023
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
  • 批准号:
    10822182
    10822182
  • 财政年份:
    2023
  • 资助金额:
    $ 9.87万
    $ 9.87万
  • 项目类别: